Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study
Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study
Vistagen Therapeutics
Private
Biopharmaceutical company. See news coverage for latest developments.